Table 2 Three-level model analysis of individual characteristics and Spatiotemporal effects influencing tuberculosis treatment failure.
Variable | Level | \(\:\widehat{\beta\:}\) | SE | RR (95% CI) | P value |
|---|---|---|---|---|---|
Fixed parameter | β0 | -7.704 | 0.433 | – | 0.000 |
Age | – | 0.310 | 0.052 | 1.4 (1.2,1.5) | 0.000 |
Sex (female as ref.) | Male | 0.461 | 0.060 | 1.6 (1.4,1.8) | 0.000 |
Diagnosis classification (other types* as ref.) | Hematogenous dissemination | 2.657 | 0.524 | 14.3 (5.1,39.9) | 0.000 |
| Â | Secondary | 2.267 | 0.390 | 9.6 (4.5,20.8) | 0.000 |
Etiology (negative as ref.) | Positive | 2.063 | 0.076 | 7.9 (6.8,9.2) | 0.000 |
Comorbidity (none as ref.) | Pneumoconiosis | 0.335 | 0.535 | 1.4 (0.5,4.0) | 0.532 |
| Â | Diabetes/chronic disease | 0.300 | 0.075 | 1.3 (1.2,1.6) | 0.000 |
Registration classification (new case as ref.) | Initial treatment failure | 0.972 | 0.122 | 2.6 (2.1,3.4) | 0.000 |
| Â | Relapse | 0.777 | 0.076 | 2.2 (1.9,2.5) | 0.000 |
Time delayed in treatment (≤ 30 days as ref.) | > 30 days | 0.146 | 0.057 | 1.2 (1.0,1.3) | 0.011 |
Random parameters | Area of case management (three-Level) \(\:{{\upsigma\:}}_{\text{v}}^{2}\) | 0.045 | 0.025 | – | 0.071 |
|  | Treatment year (two-Level)\(\:{{\upsigma\:}}_{\text{u}}^{2}\) | 0.042 | 0.017 | – | 0.011 |
|  | Case (one-Level)\(\:{{\upsigma\:}}_{{\upepsilon\:}}^{2}\) | 1 | – | – | – |